Why is Indrayani Biotec falling/rising?

As of 10-Sep, Indrayani Biotech Ltd's stock price is currently at 12.41, reflecting an increase of 0.17 or 1.39%. The stock has shown a positive trend recently, gaining 3.42% over the past week and has been on a consecutive gain for the last two days. However, despite this short-term rise, the company has faced significant challenges, including a weak long-term fundamental strength indicated by a -253.18% CAGR growth in operating profits over the last five years and a high Debt to EBITDA ratio of 7.34 times. The company has reported negative results for the last five consecutive quarters, with a notable decline in both profit before tax and profit after tax, which has contributed to a perception of risk among investors.
In the broader market context, the stock's short-term performance of +3.42% over the past week outpaces the Sensex's gain of +1.06% during the same period. However, the stock has consistently underperformed against the benchmark over the last three years, with a staggering -74.15% return in the past year compared to the Sensex's -0.61%. This consistent underperformance, coupled with falling participation from institutional investors, who have reduced their stake by -0.55%, suggests a lack of confidence in the company's future prospects, despite the recent uptick in price.